GeekWire July 24, 2024
Oisín Biotechnologies, a Seattle-based startup focused on treating aging-related diseases, raised the first close of a $15 million Series A round.
- The company is developing preclinical therapies to eliminate unwanted fat cells and build muscle mass to address frailty.
- Oisín was founded in 2016...